Navigation Links
Boston University School of Medicine's pulmonary center receives $1.4 million grant

(Boston) Boston University School of Medicine's (BUSM) Pulmonary Center has received a two-year $1.4 million grant from the National Heart, Lung, and Blood Institute to derive stem cells and lung progenitors from patients with lung disease.

Darrell Kotton, MD, associate professor of medicine and pathology, and Gustavo Mostoslavsky, MD, PhD, assistant professor of medicine, are the principal investigators of this new grant award. Together Kotton and Mostoslavsky lead a multicenter investigative team of five Boston University laboratories together with two labs at the University of Pennsylvania and the University of Vermont. The investigators plan to use the grant to derive induced pluripotent stem (iPS) cells from skin cells taken from individuals with inherited lung diseases and use them to derive new lung precursor cells. The newly derived cells will be compared to the cells made from individuals without inherited lung diseases and will also be compared to cells made from embryonic stem cells in an effort to better understand the biology of pluripotent stem cells and to develop novel treatments for lung diseases, such as emphysema and cystic fibrosis.

"It is a tremendous privilege to receive this grant from the National Heart, Lung and Blood Institute," said Kotton. "We now have the opportunity to make major headway in understanding how the lung develops as well as regenerates after injury."

Kotton's research focuses on stem cell biology and gene therapy related to lung injury and repair. He is a principal investigator in the Boston University Pulmonary Center and a member of several research groups, including the Pulmonary Developmental Biology Group. Kotton and Mostoslavsky's laboratories work closely together to understand the biology of stem cells, focusing on the signals that tell pluripotent stem cells how to develop and form new tissues, such as lung, intestinal, or blood cells.

This year, Kotton and Mostoslavsky became co-directors of the Boston University Center for Regenerative Medicine (CReM), bringing together several research groups to focus on various aspects of stem cell biology and regenerative medicine. CReM's goal is to advance research in stem cell biology using the embryo's normal development as a 'road map' for how to control the development of stem cells.


Contact: Michelle Roberts
Boston University Medical Center

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces New Initiatives to Increase Shareholder Value
7. Boston Scientific Announces Additions to Clinical Sciences Organization
8. Boston University School of Medicine physician receives award from AATOD
9. Boston Scientific Announces Verdict in Cordis Litigation
10. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology: